The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

A NEW IDEA ON CHINA’S TESLA NIO LIMITED $NIO $TSLA

September 14, 2018

This post was just published on ZYX Short Sell Change Alert. We will shortly publish a more detailed post.  This is suitable only for super aggressive investors. The short zone for NIO Limited (NIO)  is $13.70 to $15.88.  Stop zone is $16.26 to $16.78.  First target zone is $6.26 to $8.52. The second target zone is $4 to $5.11.  Maximum recommended quantity is 20% of full core position size.   You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE 

Read More »

A NEW IDEA TO SHORT BIOTELEMETRY ON COMPETITION FROM NEW APPLE iWATCH $BEAT $AAPL

September 12, 2018

This post was just published on ZYX Short Sell Change Alert. Biotelemetry (BEAT) provides cardiac monitoring services including remote monitoring for electrophysiologist.  The new Apple Watch (AAPL) has an ECG function and is approved by the FDA.  This may not have an immediate effect on BEAT’s business but in the long run it is a negative.  Technically the stock is very overbought.  The short zone is $58.00 to $62.75.  The first target zone is $52 to $54.  The second target zone is $44 to $46 and then $30 to $32.  Stop zone is $63.11 to $65.58.  Maximum position size is 30% of full core position size.   BEAT is

Read More »

26 TRADING OPPORTUNITIES FROM HURRICANE FLORENCE $HD $LOW $GNRC $HTZ $PGR $TRV $ALL $KIE $CCL $RCL $AAL $UAL $JBLU $DUK $SCG $SUM $VMC $MLM $CAR

September 12, 2018

My hopes and prayers are that Hurricane Florence does not cause much damage. Still, investors need to protect their portfolios. And there might even be trading opportunities if share prices get out of whack. As a result, consider the following three scenarios: • Damage is less than expected. • Damage is in line with expectations. • Damage is worse than expected. Let’s explore with the help of a chart. Chart Please click here for the annotated chart of Lowe’s LOW  stock. Please note the following: • Lowe’s is essentially a large hardware store. It is already benefiting as people rush to

Read More »

PAY HEED TO THE EARLY WARNING SIGNAL FROM SHIFTS IN MONEY FLOWS IN 11 POPULAR TECH STOCKS $AAPL $AMZN $FB $BABA $AMD $GOOG $GOOGL $NFLX

September 11, 2018

Technology stocks have been the generals of this U.S. bull market. But a dramatic change in money flows is beginning to happen in popular tech stocks. If this continues, the stock market will be at higher risk. Think of this as an early warning that all prudent investors should heed. Let’s explore this issue with the help of a chart. Chart Please click here for a chart showing segmented money flows, risk-adjusted rankings and non-risk-adjusted rankings of 11 popular tech stocks. Please note the following from the chart: • The most dramatic change has been in money flows in Apple

Read More »

TAKE MORE PROFITS ON ACORDA AND EXIT THE POSITION WITH A PLAN TO RE-ENTER $ACOR

September 11, 2018

This post was just published on ZYX Short Sell Change Alert. On a fundamental basis, the prior target makes sense.  However since Acorda (ACOR) is a short term trade, trading is not about making sense but making money.  Technically oriented traders who do not always understand fundamentals are passing around buy signals on ACOR.  Because of such buying money flow is beginning to turn positive. Some of the brokers who have been bullish on ACOR are also coming to its defense.  It is simply prudent to go ahead and take the profits on the entire position in the zone of $19 to $20.15

Read More »

TAKE PARTIAL PROFITS ON ACORDA $ACOR

September 11, 2018

These posts were published on ZYX Short Sell Change Alert. Consider taking profits on one-half of Acorda (ACOR) in the zone of $20 to $21.05.  Stop on the remaining is $21.55 to $22.36.   You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE  30 day trial. Check out our enviable performance in both bull and bear markets.

Read More »

A NEW IDEA ON BIOTECH COMPANY ACORDA ON PATENT INVALIDATION $ACOR $MYL $TEVA

September 10, 2018

These posts were published on ZYX Short Sell Change Alert. The short zone for Acorda Therapeutics (ACOR) is $24.50 to $26.40.  Since the stock is moving fast we want to get this to you quickly.  We will do another post shortly with more details. Maximum position size is 30% of full core position size. MORE ON ACOR We have a long history with Acorda Therapeutics (ACOR) from years ago when ACOR started talking about its drug Ampyra, long before the approval of the drug.  We have repeatedly been proven right and in the process have made a lot of money. Ampyra is responsible for

Read More »

HOW BIG TOBACCO MAY BE A STEP TOWARDS MARIJUANA INVESTORS BECOMING MULTIMILLIONAIRES $CGC $MO $STZ $TLRY $MJ $NEPT $ACBFF $CRON $DEO $BTI $TPB

September 10, 2018

The next catalyst for marijuana investors may come from an obvious place: Big Tobacco. While alcoholic-beverage companies have been active in the marijuana industry, Big Tobacco curiously has not. But new comments made by an Altria MO  executive show that the company is evaluating opportunities in marijuana. Altria owns Phillip Morris USA, which makes Marlboro cigarettes. Before digging deeper into the logic of cigarette companies getting into marijuana, let’s review marijuana stocks with the help of a chart. Chart Please click here for an annotated chart of marijuana stock Canopy Growth CGC. Please note the following: • The chart shows

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content